Natco Pharma Ltd
NSE:NATCOPHARM
Natco Pharma Ltd
NSE:NATCOPHARM
Price:
882.6
INR
0.13%
Market Closed
Market Cap:
₹158.1B
Relative Value
The Relative Value of one
NATCOPHARM
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 882.6 INR,
Natco Pharma Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NATCOPHARM Relative Value
HIDDEN
Multiples Across Competitors
NATCOPHARM Competitors Multiples
Natco Pharma Ltd Competitors
Natco Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Natco Pharma Ltd
NSE:NATCOPHARM
|
158.1B INR | 3.6 | 10.3 | 6.9 | 8.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
983.7B USD | 15.1 | 47.7 | 32.1 | 34.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.2B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
289.4B CHF | 4.7 | 31 | 13.1 | 15.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
244.8B CHF | 5.6 | 22.6 | 13.9 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| UK |
|
GSK plc
XETRA:GS71
|
104B EUR | 2.8 | 15.8 | 8 | 11.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
